Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
41.19
+1.14 (2.85%)
Apr 29, 2026, 3:00 PM CST
SHA:600211 Market Cap
SHA:600211 has a market cap or net worth of 13.28 billion as of April 29, 2026. Its market cap has increased by 8.20% in one year.
Market Cap
13.28B
Enterprise Value
11.01B
Revenue
2.98B
Ranking
n/a
PE Ratio
14.15
Stock Price
41.19
Market Cap Chart
Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 13.28B, an increase of 816.84%. That is a compound annual growth rate of 8.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 12.91B | -5.88% |
| Dec 31, 2025 | 13.71B | 15.19% |
| Dec 31, 2024 | 11.91B | -1.59% |
| Dec 29, 2023 | 12.10B | 35.86% |
| Dec 30, 2022 | 8.91B | -31.40% |
| Dec 31, 2021 | 12.98B | -22.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Medicine | 13.85B |
| Zhejiang Hisun Pharmaceutical | 13.53B |
| Guobang Pharma | 13.33B |
| Shenzhen Chipscreen Biosciences | 13.08B |
| Shanghai Shyndec Pharmaceutical | 12.82B |
| Henan Lingrui Pharmaceutical | 12.71B |
| Zhejiang Jiuzhou Pharmaceutical | 12.48B |
| Ningbo Menovo Pharmaceutical | 12.44B |